Ir al contenido
Georgia Commons

Código Oficial de Georgia Anotado

Título 31. HEALTH · Capítulo 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES · Artículo 2. INDIVIDUALIZED INVESTIGATIONAL TREATMENT

31-52-21. Physician documentation of eligibility.

Vigente

Actualizado hasta: Including Acts of the 2025 Session of the General Assembly of Georgia.

El texto siguiente es la ley tal como la imprime el estado, en inglés.

  1. In order for a person to be considered an eligible patient to access an individualized investigational treatment pursuant to this article, a physician must document in writing that the person:

  2. (1)

    Has a life-threatening or severely debilitating illness;#

  3. (2)

    Has, in consultation with the physician, considered all other treatment options currently approved by the United States Food and Drug Administration;#

  4. (3)

    Has been given a recommendation by the physician for an individualized investigational treatment based on an analysis of such patient’s genomic sequence, human chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products such as enzymes and other types of proteins, or metabolites; and#

  5. (4)

    Has given written informed consent for the use of the individualized investigational treatment.#

Las notas siguientes se imprimen con la sección, pero no son ley promulgada (O.C.G.A. § 1-1-1(c)). Se muestran aparte del texto.

History

Code 1981, § 31-52-21, enacted by Ga. L. 2025, p. 455, § 5/SB 72, effective July 1, 2025.

Leer la página oficial (el PDF del estado, abierto en la página de la que se leyó este texto).

Actualizado hasta: Including Acts of the 2025 Session of the General Assembly of Georgia.

Texto leído de t31-(v23)-2025-pdf.pdf, Volumen V23, edición 2025, página 1093; acción de fusión: bound only; SHA-256 del archivo ba5a57f85d04.